Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy
Devy Deliyanti(Monash University), Jennifer L. Wilkinson‐Berka(The University of Melbourne)
Cited by 72
Related Papers
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy
|International Journal of Molecular Sciences|2023|32
Early Depletion of Neutrophils Reduces Retinal Inflammation and Neovascularization in Mice with Oxygen-Induced Retinopathy
|International Journal of Molecular Sciences|2023|19
Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy
|Journal of Inflammation|2025|1